[HTML][HTML] Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice
J Zhang, M Huang, S Shen, X Wu, X Wu… - American Journal of …, 2017 - ncbi.nlm.nih.gov
Background: To further explore the role of PPARγ in QL treatment, ISO-induced mice model
and following methods were established. Methods: Cardiac remodeling on mice model was …
and following methods were established. Methods: Cardiac remodeling on mice model was …
Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
In a multicenter randomized double-blind study we demonstrated that Qiliqiangxin (QLQX), a
traditional Chinese medicine, had a protective effect in heart failure patients. However …
traditional Chinese medicine, had a protective effect in heart failure patients. However …
[HTML][HTML] Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction
J Wang, J Zhou, X Ding, L Zhu, K Jiang… - … Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Objective: It has been reported that Qiliqiangxin (QL), a traditional Chinese medicine
compound, could inhibit cardiac hypertrophy and remodeling, and improve cardiac function …
compound, could inhibit cardiac hypertrophy and remodeling, and improve cardiac function …
[HTML][HTML] Qiliqiangxin attenuates adverse cardiac remodeling after myocardial infarction in ovariectomized mice via activation of PPARγ
S Shen, H Jiang, Y Bei, J Zhang, H Zhang… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: This study was designed to investigate the therapeutic effect of traditional
Chinese medication Qiliqiangxin (QLQX) on adverse cardiac remodeling after myocardial …
Chinese medication Qiliqiangxin (QLQX) on adverse cardiac remodeling after myocardial …
[HTML][HTML] Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF-β1/Smad3 and NF-κB signaling pathways in a rat model of myocardial infarction
A Han, Y Lu, Q Zheng, J Zhang, YZ Zhao… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: Qiliqiangxin (QL), a traditional Chinese medicine, has been
demonstrated to be effective and safe for the treatment of chronic heart failure. Left …
demonstrated to be effective and safe for the treatment of chronic heart failure. Left …
[HTML][HTML] Traditional Chinese medication Qiliqiangxin protects against cardiac remodeling and dysfunction in spontaneously hypertensive rats
H Wang, X Zhang, P Yu, Q Zhou, J Zhang… - … Journal of Medical …, 2017 - ncbi.nlm.nih.gov
Qiliqiangxin (QLQX), a traditional Chinese herbs medication, exerted protective effect in
chronic heart failure patients in a multicenter randomized double-blind study. QLQX has also …
chronic heart failure patients in a multicenter randomized double-blind study. QLQX has also …
[HTML][HTML] Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α
RR Gao, XD Wu, HM Jiang, YJ Zhu… - Annals of …, 2018 - ncbi.nlm.nih.gov
Background Clinical study has demonstrated that the traditional Chinese medicine
Qiliqiangxin (QLQX) has protective effects on heart failure. Phenylephrine (PE) is an …
Qiliqiangxin (QLQX) has protective effects on heart failure. Phenylephrine (PE) is an …
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
X Sun, G Chen, Y Xie, D Jiang, J Han… - Pharmaceutical …, 2020 - Taylor & Francis
Context Therapeutic doxorubicin administration is restricted as this anticancer drug may be
cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical …
cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical …
Traditional Chinese medication qiliqiangxin attenuates diabetic cardiomyopathy via activating PPARγ
X Wu, T Zhang, P Lyu, M Chen, G Ni… - Frontiers in …, 2021 - frontiersin.org
Background: Diabetic cardiomyopathy is the primary complication associated with diabetes
mellitus and also is a major cause of death and disability. Limited pharmacological therapies …
mellitus and also is a major cause of death and disability. Limited pharmacological therapies …
[PDF][PDF] Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.
JM Hao, P Sun, Y Zeng, H Zhang… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: The aim of this study was to investigate the protective effect and mechanism of
action (MOA) of Qiliqiangxin capsule (QL) in the deoxycorticosterone acetate (DOCA) salt …
action (MOA) of Qiliqiangxin capsule (QL) in the deoxycorticosterone acetate (DOCA) salt …